Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
about
Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practiceManagement of persons with co-occurring severe mental illness and substance use disorder: program implications.Benzodiazepine Dependence among Young Adult Participants in the Club Scene Who Use Drugs.Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.Alcohol withdrawal kindling: is there a role for anticonvulsants?Suicidal behavior among physicians referred for fitness-for-duty evaluation.Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.Benzodiazepine dependence among multidrug users in the club scene.An audit of first prescription of new patients attending a psychiatry walk-in-clinic in north IndiaBenzodiazepine prescription for patients in treatment for drug use disorders: a nationwide cohort study in Denmark, 2000-2010.Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.A Lifetime Prevalence of Comorbidity Between Bipolar Affective Disorder and Anxiety Disorders: A Meta-analysis of 52 Interview-based Studies of Psychiatric PopulationAdvising depression patients to reduce alcohol and drug use: factors associated with provider intervention in outpatient psychiatry.Motivational interviewing to reduce hazardous drinking and drug use among depression patients.Professionals' perception on the management of patients with dual disorders.A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety DisorderAssessment of disease management of insomnia at community pharmacies through simulated visits in Pakistan.Transdiagnostic treatment of bipolar disorder and comorbid anxiety with the unified protocol: a clinical replication seriesBenzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes.Long-term Benzodiazepine Treatment in Patients with Psychotic Disorders Attending a Mental Health Service in Rural Greece.Determinants of Quality of Life in High-Dose Benzodiazepine Misusers.Zebrafish models to study drug abuse-related phenotypes.Benzodiazepine Maintenance Treatment in Schizophrenia.Benzodiazepine prescription among patients with severe mental illness and co-occurring alcohol abuse/dependence in Taiwan.Drug misuse and diversion in adults prescribed anxiolytics and sedatives.Clonazepam as agonist substitution treatment for benzodiazepine dependence: a case report.Association between nonmedical use of prescription drugs and sleep quality in a large college student sample.Transdiagnostic treatment of bipolar disorder and comorbid anxiety using the Unified Protocol for Emotional Disorders: A pilot feasibility and acceptability trial.Socio-demographic, lifestyle and psychological predictors of benzodiazepine and z-hypnotic use patterns.Psychiatrist decision-making towards prescribing benzodiazepines: the dilemma with substance abusers.Co-use of Alcohol and Cannabis: A Review
P2860
Q26800235-B6428471-C5FB-4BA8-AA8B-DB112DEF5D3AQ30367085-9A5EC991-318F-45C5-92B3-5ABD77740258Q30396711-11075F4E-D23F-4F80-8F3D-789B5B70FEE1Q33961092-ABC113CD-1846-4950-90FB-DDD3255C9311Q34396593-A2325D3E-6492-49B9-8E05-A080DE2A68A0Q34623477-0CF887B4-CBAB-490F-A4BD-FEA2A58BBFC9Q34823805-7FF33E9A-8D24-4669-A05B-31388C9640CFQ35489297-BEAA8A6F-DB67-4A5B-86DC-C6E5391E0E45Q36021004-FAC5E988-BD59-4FED-80DB-6EE2AE078C45Q36032982-F6211375-2AB9-492B-80F1-66061F919F98Q36205791-F719F852-E9D5-473E-AC9F-A7D760E0AF54Q36253396-0A74717E-0C21-4315-8A2A-6EC674046494Q36577865-D383028B-95E6-4584-8F22-EDAFB26C2C47Q36859576-65CD8487-763F-48AD-B990-8D0B47533B1FQ37279671-A90E850B-4C3A-4B20-9978-036C419CE297Q37299931-D2912A5E-7113-468E-9DB8-1EA138ABA4C8Q37407199-D71C2625-13C3-4BD6-ABBF-9A743E3FB6FEQ37553538-FE26B27E-5E31-40E2-8C34-9508A736C14CQ37565076-BFAB7F2F-0DCB-4FE3-9EC0-40AE53BC0A42Q37592998-4188BF60-7AC2-47CC-8CA7-72A6B43461F1Q37628742-87D4CFB6-1A5B-4F72-A8F3-34E3E88EAF08Q37880096-31DE8E96-42A3-40C2-83D7-0CC4A4E8D0A4Q39419829-E20B645D-5EA7-4CBE-B3FE-E37E4064EF37Q39739580-8621304C-484D-4372-A186-1B29FC1F83A8Q39777283-D58EA727-CD15-4C6D-9BBD-7E2635BDA1ADQ43248865-8F865ECB-0559-4E0C-905A-50FCB94C9B35Q45072797-F524FD5F-20CB-4254-8471-C7FD2E6EED81Q47317037-24508315-6E3D-486B-8625-F3E281A810EEQ48187645-79744627-33DA-461B-B7E4-00CD3630A55AQ50582047-416D7614-504B-4989-8D82-9544676B2ECFQ56481718-01CD213D-0079-4DDF-A40C-68AF49147333
P2860
Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Benzodiazepine use and abuse a ...... rring substance use disorders.
@en
Benzodiazepine use and abuse a ...... rring substance use disorders.
@nl
type
label
Benzodiazepine use and abuse a ...... rring substance use disorders.
@en
Benzodiazepine use and abuse a ...... rring substance use disorders.
@nl
prefLabel
Benzodiazepine use and abuse a ...... rring substance use disorders.
@en
Benzodiazepine use and abuse a ...... rring substance use disorders.
@nl
P2093
P1433
P1476
Benzodiazepine use and abuse a ...... rring substance use disorders.
@en
P2093
Douglas L Noordsy
Mary F Brunette
P304
P356
10.1176/APPI.PS.54.10.1395
P577
2003-10-01T00:00:00Z